In addition to a slower replication rate compared to tumour cells, non-cancerous cells like H-6037 display a full complement of DNA repair pathways, thus compensating for the chemically-induced loss of individual DDR pathways [28] and mitigating RAD51-BRCA inhibitor/olaparib impact on cell viability. Here, RAD51 is linked to neoplasm.